Options
Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Gene therapy
l-dopa
Molecular mechanisms
Parkinson’s disease
Transplantation thera...
3 (3,4 dihydroxypheny...
aromatic levo amino a...
aurantiin
baicalein
curcumin
daidzein
epigallocatechin gall...
esculin
genistein
ginkgolide B
ginsenoside Rb 1
ginsenoside Rd
ginsenoside Re
ginsenoside Rg 1
guanosine triphosphat...
hyperin
isorhynchophylline
levodopa
magnolol
puerarin
quercetin
resveratrol
salvianolic acid B
stepholidine
tetramethylpyrazine
thymoquinone
triptolide
tyrosine 3 monooxygen...
umbelliferone
unindexed drug
biological product
brain depth stimulati...
cell therapy
chemogenetics
CRISPR-CAS9 system
genetic procedures
human
human embryonic stem ...
immunotherapy
mesencephalic tissue
molecular therapy
motor performance
nonhuman
nuclear reprogramming...
optogenetics
Parkinson disease
pluripotent stem cell...
quality of life
Review
RNAi therapeutics
stem cell transplanta...
treatment response
viral gene delivery s...
animal
biological model
cell transplantation
gene editing
gene therapy
immunology
Parkinson disease
Animals
Biological Products
Cell Transplantation
Gene Editing
Genetic Therapy
Humans
Models, Biological
Parkinson Disease